Stock data
Translational Development Acquisition Corp. (TDAC)
Translational Development Acquisition Corp. (TDAC) reported net income of US$6.36M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$0.94M | US$6.36M | — |
| 2024 | — | — | -US$0.20M | -US$0.07M | — |
| 2023 | — | — | -US$0.49M | -US$0.49M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$0.95M | — |
| 2026-03-31 | — | US$1.33M | — |
| 2025-12-31 | — | US$1.60M | — |
| 2025-09-30 | — | US$1.66M | — |
| 2025-06-30 | — | US$1.62M | — |
| 2025-03-31 | — | US$1.48M | — |
| 2024-12-31 | — | -US$0.01M | — |
| 2024-09-30 | — | -US$0.06M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.